PHOENIX, Oct. 29, 2017 (GLOBE NEWSWIRE) — INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the company”) today accepted the resignation of Patrick P. Fourteau from its Board of Directors effective immediately. Mr. Fourteau cited personal reasons for stepping down from the board.